Grzegorz (Greg) T. Gurda, MD, PhD

Specialties: Pathology and Molecular Genetics

Main Location

La Crosse Campus

1900 South Avenue La Crosse, WI 54601
Office Phone: (608) 775-2262

Fax: (608) 775-6666

Profile

Medical Interests

Breast Pathology, Gynecologic Pathology, Pancreatic Pathophysiology, Genomics, Molecular Diagnostics

Personal Interests

Dr. Gurda is a practicing surgical pathologist at Gundersen Lutheran Hospital, and serves as a medical director for the biobank and molecular oncology at the Gundersen Medical Foundation/Kabara Cancer Institute. He was elected as a fellow of the College of American Pathology and is an adjunct assistant professor at University of Wisconsin - La Crosse (UW-L).

My interests lie at the intersection of endocrinology and neoplasia, particularly gastroenterology and women's health (breast and GYN oncology). My goal is to combine molecular diagnostics and histomorphology analytics to improve care for important, but hard to recognize forms of common cancers.

Education and Training

Medical School

University of Michigan Medical School

Residency

Johns Hopkins Hospital, Anatomic & Clinical Pathology

Fellowship

University of Pittsburgh Medical Center

Professional Memberships

College of American Pathologists (CAP)
Association for Molecular Pathology (AMP)

Certification

Anatomic/Clinical Pathology - American Board of Pathology
Molecular Genetic Pathology - American Board of Medical Genetics and Genomics

Published Works

Meier DR, Lofgren KA, Gurda GT, Kenny PA. Adaptation of an amplicon-based human cancer next-generation sequencing panel assay for murine tumors. Anal Biochem. 2018;551:26-28. doi: S0003-2697(18)30460-3 [pii]
Parsons BM, Meier DR, Gurda GT, Lofgren KA, Kenny PA. Emergence of MET D1228N mutation as a resistance mechanism following an exceptional response to crizotinib in a MET-amplified triple-negative breast cancer patient. 2018
Van Every MJ, Dancik G, Paramesh V, et al. Genomic case report of a low grade bladder tumor metastasis to lung. BMC Urol. 2018;18(1):74-018-0386-8. doi: 10.1186/s12894-018-0386-8 [doi]
Gurda GT, Serdy KM, Yatsenko SA, et al. Synchronous bilateral tubal serous carcinomas in a patient with Exon 13 duplication and loss of function of BRCA1. Int J Gynecol Pathol. 2017. doi: 10.1097/PGP.0000000000000392 [doi]
Kota K, Bossart EA, Basudan A, et al. Generation and characterization of a novel invasive lobular breast carcinoma cell line WCRC-25. 2017
Parsons BM, Meier DR, Gurda GT, Lofgren KA, Kenny PA. Exceptional response to crizotinib in an MET-amplified triple-negative breast tumor. JCO Precis Oncol. 2017(1):1-6. doi: 10.1200/PO.17.00070
Gurda GT, Bhargava R, Surti U. Testing IHC equivocal human epidermal growth factor receptor 2 (ERBB2/HER2) samples by FISH:Â impact of updated 2013 ASCO/CAP Breast Cancer Guidelines. 2016
Blasko B, Kolka R, Thorbjornsdottir P, et al. Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction. Int Immunol. 2008;20(1):31-37. doi: 10.1093/intimm/dxm117
Arason GJ, Kramer J, Blasko B, et al. Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol. 2007;149(1):132-138. doi: 10.1111/j.1365-2249.2007.03391.x
Arason GJ, Bodvarsson S, Sigurdarson ST, et al. An age-associated decrease in the frequency of C4B*Q0 indicates that null alleles of complement may affect health or survival. Ann N Y Acad Sci. 2003;1010:496-499